BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 18286613)

  • 21. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal-associated nephropathy in patients with brushite nephrolithiasis.
    Evan AP; Lingeman JE; Coe FL; Shao Y; Parks JH; Bledsoe SB; Phillips CL; Bonsib S; Worcester EM; Sommer AJ; Kim SC; Tinmouth WW; Grynpas M
    Kidney Int; 2005 Feb; 67(2):576-91. PubMed ID: 15673305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of Randall's plaques in the pathogenesis of calcium stones.
    Matlaga BR; Coe FL; Evan AP; Lingeman JE
    J Urol; 2007 Jan; 177(1):31-8. PubMed ID: 17161996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hyperuricosuric calcium oxalate stone former.
    Sarig S
    Miner Electrolyte Metab; 1987; 13(4):251-6. PubMed ID: 3306317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A concerted protocol for the analysis of mineral deposits in biopsied tissue using infrared microanalysis.
    Anderson J; Dellomo J; Sommer A; Evan A; Bledsoe S
    Urol Res; 2005 Jun; 33(3):213-9. PubMed ID: 15703966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
    J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteome of human calcium kidney stones.
    Canales BK; Anderson L; Higgins L; Ensrud-Bowlin K; Roberts KP; Wu B; Kim IW; Monga M
    Urology; 2010 Oct; 76(4):1017.e13-20. PubMed ID: 20709378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
    Khan SR; Glenton PA; Backov R; Talham DR
    Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxalate crystallization in the kidney in the presence of hyperuricemia.
    Noda S; Hayashi K; Eto K
    Scanning Microsc; 1989 Sep; 3(3):829-35; discussion 835-6. PubMed ID: 2617264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque.
    Wang X; Krambeck AE; Williams JC; Tang X; Rule AD; Zhao F; Bergstralh E; Haskic Z; Edeh S; Holmes DR; Herrera Hernandez LP; Lieske JC
    Clin J Am Soc Nephrol; 2014 Oct; 9(10):1757-63. PubMed ID: 25092598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Observations on calcium oxalate stone formers.
    el-Sharabasy MM
    Br J Urol; 1992 Nov; 70(5):474-7. PubMed ID: 1361403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ
    Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An architectural study of mixed uric acid and calcium oxalate stones by polarized light microscopy of thin section].
    Takeuchi H; Arai Y; Konishi T; Tomoyoshi T
    Hinyokika Kiyo; 1988 Sep; 34(9):1529-35. PubMed ID: 3213788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.